Virginia Commonwealth University ( Site 0233) — Richmond, Virginia

Virginia Commonwealth University ( Site 0233) is a clinical research site located in Richmond, Virginia, United States 23219.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Virginia Commonwealth University ( Site 0233) has participated in 1 clinical trials.

Therapeutic areas: Squamous Cell Carcinoma of Head and Neck.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Virginia Commonwealth University ( Site 0233)?

Virginia Commonwealth University ( Site 0233) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Virginia Commonwealth University ( Site 0233) conducted?

Virginia Commonwealth University ( Site 0233) has 1 clinical trials on record. Their work covers Squamous Cell Carcinoma of Head and Neck.

Is Virginia Commonwealth University ( Site 0233) accredited by Crixeo Health?

Virginia Commonwealth University ( Site 0233) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Virginia Commonwealth University ( Site 0233)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.